Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury
Top Cited Papers
- 7 February 2020
- journal article
- editorial
- Published by Elsevier BV in The Lancet
- Vol. 395 (10223), 473-475
- https://doi.org/10.1016/s0140-6736(20)30317-2
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- The Effect of Steroid Use in Hospitalized Adults With Respiratory Syncytial Virus-Related IllnessChest, 2011
- Hemodynamic impact of a positive end-expiratory pressure setting in acute respiratory distress syndrome: Importance of the volume status*Critical Care Medicine, 2010
- Use of Corticosteroids in Treating Infectious DiseasesArchives of Internal Medicine, 2008
- A Multicenter, Randomized, Controlled Trial of Dexamethasone for BronchiolitisNew England Journal of Medicine, 2007
- SARS: Systematic Review of Treatment EffectsPLoS Medicine, 2006
- Early Enhanced Expression of Interferon-Inducible Protein-10 (CXCL-10) and Other Chemokines Predicts Adverse Outcome in Severe Acute Respiratory SyndromeClinical Chemistry, 2005
- Factors Associated with Psychosis among Patients with Severe Acute Respiratory Syndrome: A Case-Control StudyClinical Infectious Diseases, 2004
- Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patientsJournal of Clinical Virology, 2004
- Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective studyThe Lancet, 2003
- ACUTE RESPIRATORY DISTRESS IN ADULTSThe Lancet, 1967